3 resultats
OBJECTIVE
To determine the efficiency of YAG-laser vitreolysis in patients with diabetic vitreous hemorrhage.
METHODS
The study enrolled 56 patients (61 eyes) with proliferative diabetic retinopathy complicated by vitreous hemorrhage aged 36-69 years, including 31 women (34 eyes) and 25 men (27
ISTA Pharmaceuticals (formerly Advanced Corneal Systems) has developed an ophthalmic injectable formulation of highly purified hyaluronidase [ovine hyaluronidase, Vitrase] for the initial treatment of vitreous haemorrhage and diabetic retinopathy. Hyaluronidase is a naturally occurring enzyme that
Ocular complications to diabetes may be described as early or late, the late ones being by far the most important. Early complications are the frequently occuring transitory changes in refraction, and the more serious but rarely occuring diabetes cataract both possibly related to an overloading of